Biomimetic Nanoparticle Characterization for Dilated Cardiomyopathy Treatment

Chenghua Wang published a dataset on figshare in April 2026 detailing the synthesis and characterization of astragaloside-IV-loaded nanoparticles. The dataset likely contains measurements of particle size, zeta potential, drug loading capacity, encapsulation efficiency, and in vitro/in vivo therapeutic effects. The file is 41.5 KB and is licensed under CC-BY-4.0.

Use Cases

• Analyze nanoparticle stability based on zeta potential and serum stability tests mentioned in the description
• Evaluate drug delivery efficiency based on loading capacity and encapsulation efficiency metrics
• Assess therapeutic efficacy based on in vitro cell proliferation and in vivo cardiac function improvement data

Strengths

• Specific particle characterization metrics are provided, including average size of 234 nm and zeta potential of -24.5 mV
• Drug loading and encapsulation efficiency are quantified at 9.5% ± 0.04% and 98.9% ± 0.1%

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download

Provenance

Source

figshare

Collection Method

Likely contains experimental data from the preparation and testing of nanoparticles.

Freshness

Last updated 2026-04-09 05:14:51